Moderna

News

ASCO: Moderna, Merck melanoma vaccine set for phase 3

Moderna’s move into personalised cancer therapy continues to proceed at a rapid pace, with Merck & Co-partnered melanoma vaccine mRNA-4157 heading for a pivotal phase

R&D

From Covid to cancer: Moderna’s new challenge

In the autumn of 2021, I had the pleasure and misfortune of presenting at a conference straight after Moderna chief executive Stéphane Bancel.

News

Moderna tags IBM for quantum leap in mRNA research

Moderna and IBM have formed a partnership to see how cutting-edge technologies like generative artificial intelligence and quantum computing could be applied to the discov

News

Merck, Moderna cue up phase 3 trials for mRNA cancer shot

Moderna and partner Merck & Co have fleshed out the data from their clinical trial of personalised mRNA vaccine for melanoma, saying the results support the start of a

News

Moderna’s flu vaccine trial delayed by case numbers

Moderna’s aspiration to become a player in the seasonal influenza vaccine market has hit a hurdle – likely a delay rather than anything more serious – but its stock has st

News

J&J decides not to play catch-up in RSV vaccination

Johnson & Johnson has decided to bow out of the market for respiratory syncytial virus (RSV) vaccines, abandoning a late-stage development programme that would have be

ASCO: Moderna, Merck melanoma vaccine set for phase 3

From Covid to cancer: Moderna’s new challenge

Moderna tags IBM for quantum leap in mRNA research

Merck, Moderna cue up phase 3 trials for mRNA cancer shot

Moderna’s flu vaccine trial delayed by case numbers

J&J decides not to play catch-up in RSV vaccination

Lilly bags FDA okay for Wegovy pill rival orforglipron

Using AI-driven synthetic personas to take your insights fur...

Moderna

Editor's Picks